FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

39088511000001103: Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (A A H Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 28-Oct 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1665251000001113 Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (A A H Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1665261000001111 Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (A A H Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (A A H Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (A A H Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (A A H Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (A A H Pharmaceuticals Ltd) Is a Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (A A H Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Magnesium true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (A A H Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (A A H Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (A A H Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (A A H Pharmaceuticals Ltd) Has specific active ingredient Magnesium glycerophosphate true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (A A H Pharmaceuticals Ltd) Has dispensed dose form Conventional release chewable tablet true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (A A H Pharmaceuticals Ltd) 50 tablet Has AMP True Magnesium glycerophosphate (magnesium 97.2mg (4mmol)) chewable tablets (A A H Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start